Hybio Pharmaceutical Co., Ltd., established in Jun 1998, is a national high-tech enterprise specializing in the research, production, and sales of peptide pharmaceuticals. The company was listed on the Shenzhen Stock Exchange in 2011 (stock code: 300199) and it is distinguished as the first peptide enterprise listed in China. With subsidiaries in Pingshan, Wuhan, Hong Kong, Gansu Chengji, and Dali, Han Yu Pharmaceuticals operates in the fields of pharmaceuticals and medical devices. Our main products include peptide raw materials, custom peptides, cosmetic peptides, peptide formulations, solid dosage forms, medical devices, and peptide skincare products.